Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ROKU should not be affected by China news.
Very tough.
Check out AU, GLD, BND
Looks like the BND will be in vogue today.
Wednesday is conference and announcements.
Tariff proof stock.
Asides from steel for towers.
I hope so.
It would make for a less stress weekend.
I'm looking at some cool Tariff proof stocks to buy after we get a big return.
The conference is next week and the Phase 3 data is late this year?
LOL!
I do love it up there.
August 7th and 8th.
I'm assuming results of the DREAM endpoints will be brought up.
Today's graph looks like the Grand Teton range.
Just received a positive BUY on The Halftime Report on CNBC.
I will when the come along, but I'm not forcing it
I can't wait to get out of spec stocks.
This is my last one, but I believe in the up coming catalysts.
All those losses heading to Roku and Amazon Firestick?
But hotels already have cable and PPV.
Not yet :(
I hope they do before the closing bell on Friday.
I don't think us home gamers affect this, or any NASDAQ or NYSE stock.
At the same time, Cramer is good about the tutorial shows, when he is on vacation and his Friday game plan, but he should have said 'I need to do work' with ZYNE, not just blow it off.
Geeze! More pain.
Topline Results Expected in the Third Quarter of 2019
Enrollment is complete in BELIEVE 1, an open label multi-dose Phase 2 clinical trial evaluating the efficacy and safety of Zygel in children and adolescents (three through 17 years) with DEE. The primary efficacy assessment is reduction in seizure frequency at week 26 compared to baseline. The Company expects to announce topline data through week 26 in the third quarter of 2019.
Yes, ZYNE was brought up again.
What's good for GW Pharma should be good for ZYNE
I like his tutorial shows.
As for individual stocks, he is not going to recommend specs.
Speaking of specs, we were supposed to hear some news today.
He said the same thing a day or two after the FastTrack announcement.
We should hear about the Dreamer Endpoints today.
I have no idea.
I'm hoping for one hour after the opening bell,, lol.
My fingers hovering over the BUY or SELL button.
Might be gamblers betting on tomorrow.
I'm holding long, but primarily for the Fragile X phase 3 results later this year.
Kiplinger hasn't been keeping up with the news from the USA.
Our Congress is, and has introduced legalization and banking bills.
At the very least edibles will be passed.
Tomorrow the DREAM end point results come out.
Nice close.
My only bright spot today.
Let's have a great weekend.
Just four more days.
No signs of insider selling.
No debt.
Fast track designation.
Not to mention ending up in the green.
You have not shared any DD.
DD is not inside information, so why not share it?
Same here,, AUGH!!
I read his Stocktwit post.
No information whatsoever, just a blanket opinion.
I see an opinion without any reasoning.
Such as?
I agree.
Any day now, Phase 3 data.
Decent close concidering no news.
Phase 3 data, due in the 3rd quarter of 2019.
Phase 3 top line data due mid 2019
Phase 3 data, mid 2019 anytime now.
Decent insider buying the past 12 months.